Clifford Capital Partners LLC Sells 21,329 Shares of Cardinal Health, Inc. $CAH

Posted by Stanley Muller on Jun 18th, 2026

Clifford Capital Partners LLC decreased its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 15.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 112,717 shares of the company’s stock after selling 21,329 shares during the quarter. Cardinal Health makes up 3.9% of Clifford Capital Partners LLC’s holdings, making the stock its 6th biggest position. Clifford Capital Partners LLC’s holdings in Cardinal Health were worth $23,163,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of CAH. Nordea Investment Management AB boosted its stake in Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after purchasing an additional 494,731 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after purchasing an additional 707,495 shares during the last quarter. Procyon Advisors LLC boosted its stake in Cardinal Health by 78.7% during the 4th quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock worth $3,499,000 after purchasing an additional 7,499 shares during the last quarter. Public Sector Pension Investment Board boosted its stake in Cardinal Health by 66.7% during the 3rd quarter. Public Sector Pension Investment Board now owns 30,007 shares of the company’s stock worth $4,710,000 after purchasing an additional 12,003 shares during the last quarter. Finally, Sierra Summit Advisors LLC acquired a new stake in Cardinal Health during the 3rd quarter worth $9,897,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on CAH. Barclays lifted their price target on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, February 24th. Leerink Partners reiterated an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. TD Cowen lifted their price target on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a report on Friday, May 1st. JPMorgan Chase & Co. reduced their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Finally, Evercore reduced their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $246.93.

Read Our Latest Report on Cardinal Health

Cardinal Health Trading Down 0.6%

Shares of CAH opened at $226.29 on Thursday. The firm has a market cap of $53.00 billion, a P/E ratio of 34.60, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60. The company’s 50-day moving average price is $204.01 and its 200 day moving average price is $209.11.

Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a $0.5158 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s payout ratio is presently 31.19%.

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.